지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Background: Increasing geriatric population, osteoporosis prevalence, and interest in bone health are key contributing factors for the growth of osteoporosis medication markets. Thus, this study evaluated changes in the menopausal hormone and other osteoporosis medication markets from 2016 to 2019. Methods: This study’s dataset was obtained from the International Marketing Services of IQVIA Inc. in South Korea. The sales of medications for osteoporosis treatment with menopausal hormones were evaluated for drug sales for osteoporosis treatment from 2016 to 2019. Results: The results showed that the tissue-selective estrogen complex (TSEC) sales had increased annually while the estrogen-progesterone therapy (EPT) sales had decreased. Excluding menopausal hormones, bisphosphonates were the most widely sold medications for osteoporosis treatment. Among the bisphosphonate medications, sales of ibandronate and zoledronate increased annually, while alendronate and risedronate decreased. Teriparatide also showed increasing sales. A rapid rise was noted in the sales of denosumab. Conclusions: While the sales of TSEC, injectable bisphosphonates, and denosumab have increased annually, the sales of EPT, estrogen therapy, oral bisphosphonates have not increased, as reflected in hormone therapy and osteoporosis medication market trends. This study showed the recent trends in hormone therapy and the osteoporosis medication market from 2016 to 2019 in South Korea.
목차
등록된 정보가 없습니다.
참고문헌 (16)
참고문헌 신청
하용찬 / 2016 / 한국 골다공증의 역학 / 대한의사협회지 59(11):836~841
Hyung Jin Choi / 2012 / Burden of osteoporosis in adults in Korea: a national health insurance database study / Journal of Bone and Mineral Metabolism 30(1):54~58
Chan Soo Shin / 2010 / Prevalence and risk factors of osteoporosis in Korea: A community-based cohort study with lumbar spine and hip bone mineral density / Bone 47(2):378~387
Dennis M. Black / 2016 / Postmenopausal Osteoporosis / New England Journal of Medicine 374(3):254~262
박형무 / 2010 / 한국의 골다공증 약제의 사용 현황 / Obstetrics & Gynecology Science 53(02):152~159
Hyung Jin Choi / 2012 / Burden of osteoporosis in adults in Korea: a national health insurance database study / Journal of Bone and Mineral Metabolism 30(1):54~58
Chan Soo Shin / 2010 / Prevalence and risk factors of osteoporosis in Korea: A community-based cohort study with lumbar spine and hip bone mineral density / Bone 47(2):378~387
Dennis M. Black / 2016 / Postmenopausal Osteoporosis / New England Journal of Medicine 374(3):254~262
박형무 / 2010 / 한국의 골다공증 약제의 사용 현황 / Obstetrics & Gynecology Science 53(02):152~159
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
A coordination project for improvement of osteoporosis medication use among patients who sustained osteoporotic fracture(s)
Osteoporosis and Sarcopenia
2019 .01
-
골다공증 치료제의 순응도
OSTEOPOROSIS
2015 .01
-
Publication Trends in Osteoporosis Treatment: A 20-Year Bibliometric Analysis
대한골대사학회지
2024 .05
-
Medical treatment of severe osteoporosis including new concept of advanced severe osteoporosis
Osteoporosis and Sarcopenia
2016 .01
-
Improvement of Osteoporosis Medication after Multimodal Intervention in Patients with Hip Fracture: Prospective Multicenter Study
대한골대사학회지
2018 .01
-
More research and education of osteoporosis should be focused on the oldest old and men
Osteoporosis and Sarcopenia
2019 .01
-
Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
대한골대사학회지
2016 .01
-
Up-to-Date Knowledge on Osteoporosis Treatment Selection in Postmenopausal Women
대한폐경학회지
2022 .12
-
The Impact of Educational Interventions on Osteoporosis Knowledge among Korean Osteoporosis Patients
대한골대사학회지
2018 .01
-
Incidence and severity of medication-related osteonecrosis of the jaw in patients with osteoporosis using data from a Korean nationwide sample cohort in 2002 to 2019: a retrospective study
Journal of Yeungnam Medical Science
2024 .01
-
폐경 후 골다공증 및 골감소증 여성의 denosumab 약물 사용 평가
한국임상약학회지
2020 .01
-
Encouraging appropriate osteoporosis medication to prevent fracture
Osteoporosis and Sarcopenia
2016 .01
-
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study
Endocrinology and Metabolism
2023 .04
-
남성 골다공증의 위험 요인에 대한 최신 지견과 공중보건학적 중재 전략
보건교육건강증진학회지
2023 .06
-
골다공증 한약제제 임상시험 참여자의골다공증 한의치료에 대한 인식 : 질적 연구
대한한방내과학회지
2017 .01
-
골다공증의 약물치료: 2022 update
대한의사협회지
2022 .04
-
Evaluation of the Predictive Index for Osteoporosis as a Clinical Tool to Identify the Risk of Osteoporosis in Korean Men by Using the Korea National Health and Nutrition Examination Survey Data
Korean Journal of Family Medicine
2016 .01
-
Comparison in Adherence to Osteoporosis Guidelines according to Bone Health Status in Korean Adult
대한골대사학회지
2016 .01
-
골다공증성 척추 골절 환자에서 생존 분석을 통한골다공증 약물 복용 지속률과 복용 인자
OSTEOPOROSIS
2015 .01
-
Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
Osteoporosis and Sarcopenia
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0